Why the cannabinoid, THCV, is something you should know about!

Edited by Admin
Why the cannabinoid, THCV, is something you should know about!
What is THCV?
 
Tetrahydrocannabivarin (THCV) is similiar to tetrahydrocannabinol (THC) but doesn't have the intoxicating effect like THC has. Despite THCV sharing a similar make-up with THC, evidence suggests that THCV interacts with the CB1 and CB2 receptors in the endocannabinoid system in a completely different way. More and more research is being done on THCV because it might better treat certain conditions compared to THC and CBD.
 
 Appetite suppressant: Evidence suggests that, at low doses ranging between 5 and 7.5 milligrams, THCV inhibits appetite by antagonizing the CB1 receptors. A 2015 study found that the effect of it on the CB1 receptors suggested a potential to treating obesity. According to Kurek, the findings of this study suggest that THCV could provide treatment without the risk of side effects found in common anti-obesity drugs, such as depression, anxiety, and insomnia.
 
Diabetes: In a 2016 study published in Diabetes Care, researchers found that CBD and THCV appeared to help patients with type 2 diabetes maintain tighter glycemic control, which is essential in preventing chronic complications from the condition. Research has also shown that, at moderate to high doses ranging between 10 and 20 milligrams, THCV regulated blood sugar levels and reduced the body's resistance to insulin.
 
Epilepsy: THCV has also been researched for its anti-epileptic properties, suggesting that it could also be used to reduce seizures for epileptic patients. A 2015 study published in the Journal of Clinical Pharmacy and Therapeutics, researchers found that THCV showcased anticonvulsant effects, significantly reducing seizure incidences in an in vitro model induced with epileptic activity.
 
Parkinson's disease: In a 2011 study on lab mice, researchers found that THCV held antioxidant properties that could prove useful in treating the symptoms and delaying neurodegeneration in Parkinson's disease.
 
Schizophrenia: A 2015 study published in the British Journal of Pharmacology, researchers found that this particular cannabinoid enhanced serotonin receptors and demonstrated antipsychotic effects in lab rats, leading the authors to conclude that THCV could provide “therapeutic potential for ameliorating some of the negative, cognitive, and positive symptoms of schizophrenia.”
 
 

Events

Get Tickets

Popular Posts